Some explanations have been proposed, including induced tumor hypoxia triggering VEGF production and vascular permeability, negative effects on the delivery of anti-tumor drugs, and tumor vascularization via alternative mechanisms (Annese et al., 2019). The gene discussed is VEGFA; the disease is neoplasm.